Position in SRRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,000,300
+$2,469,751 QoQ
Shares Held
145,460
+29.3% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#73
of 304 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. SRRK ranks #34 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in SRRK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,000,300 | 145,460 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,530,549 | 112,501 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,795,459 | 108,864 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,608,934 | 123,763 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,440,995 | 125,381 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,882,176 | 120,752 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $4,895,140 | 113,261 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $801,112 | 100,014 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $843,645 | 101,278 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,670,434 | 94,056 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,687,300 | 89,750 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $451,474 | 63,588 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $304,540 | 40,390 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $379,030 | 29,405 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $682,777 | 27,487 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $936,150 | 28,351 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $783,421 | 27,108 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,297,149 | 25,605 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,318,754 | 27,174 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $396,892 | 22,436 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $480,215 | 26,371 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $249,780 | 20,626 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||